CWCenfu Wei

Cenfu Wei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cenfu Wei has a total of 88 co-authors. Here are the top co-authors by number of shared publications:

  • Parambir S. Dulai

    Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, USA

    3 shared publications
  • Alan Robinson

    Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, USA

    2 shared publications
  • Isabella Peshek

    Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, USA

    2 shared publications
  • Ronen Sumagin

    Department of Pathology, Northwestern University Feinberg School of Medicine, 300 East Superior St., Chicago, IL 60611, USA

    2 shared publications
  • Aakash Desai

    Division of Gastroenterology, Hepatology & Nutrition, Allegheny Health Network, Pittsburgh, USA

    1 shared publication
  • Anastasiia Serdiukova

    Department of Pathology, Northwestern University Feinberg School of Medicine, 300 East Superior St. Chicago, IL 60611, USA

    1 shared publication

Latest Publications

  • Open Access

    An ulcerative colitis taxonomy defined by individual patient-reported response trajectories

    by Stefan Schreiber, Vijay Yajnik, Cenfu Wei, Maria D. Paraskevopoulou, Saman Farahmand, Jie Cheng, Katherine Simpson, Zitong Lin, Christian Agboton, Pratik Panchal, et al.

    A barrier to precision medicine for ulcerative colitis (UC) is the inability to predict and mechanistically explain treatment responses. Using patient-reported outcomes (PROs) from a phase 3b comparative trial of 768 participants, we identified four distinct patient response-trajectory groups for vedolizumab (anti-integrin) and adalimumab (antitumor necrosis factor). Validation in a second phase 3 trial of 576 participants linked PRO-defined vedolizumab trajectories to long-term disease complications. Bulk, single cell, and spatial transcriptomics and proteomics identified vascular inflammation as associated with vedolizumab nonresponse through interactions between SPP1 + macrophages and endothelial cells. In two separate real-world cohorts of 4,981 and 3,854 patients with UC, concomitant use of renin–angiotensin system inhibitors (modulators of vascular inflammation) was associated with reduced long-term complications for vedolizumab but not anticytokine therapies. These findings define a response-trajectory-based taxonomy that requires prospective validation for clinical utility and applications for selecting vedolizumab combination therapy in UC.

  • Open Access

    Identification of a spatially organized TREM2-associated permissive macrophage niche in human pulmonary tuberculosis alveolar pneumonia

    by Rosane M. B. Teles, Chaouki Benabdessalem, Jonathan Perrie, Cenfu Wei, Julie West, Bruno J. de Andrade Silva, Priscila R. Andrade, Lilah A. Mansky, Prajan Divaka, Linda Fischbacher, et al.

    Pulmonary tuberculosis (TB), caused by lung infection with Mycobacterium tuberculosis ( Mtb ), often manifests both alveolar pneumonia and aggregation of immune cells containing Mtb , termed granulomas, within the same lung. Here, we integrate spatial transcriptomics, single-cell RNA sequencing, high-resolution imaging, and functional assays of lung biopsies from four men with pulmonary TB to compare alveolar pneumonia with adjacent granulomas. We find that alveolar TB pneumonia is enriched for TREM2⁺ lipid-laden macrophages characterized by increased lipid metabolism gene expression, reduced T cell infiltration, attenuated antimicrobial gene expression, and abundant Mtb transcripts and antigens. By contrast, neighboring granulomas exhibit organized lymphoid architecture and robust antimicrobial programs. In vitro, Mtb lipids induce TREM2 expression, activate TREM2–DAP12 signaling, and promote lipid droplet accumulation in primary human monocyte-derived macrophages (MDM). Furthermore, TREM2 + MDMs are more susceptible to in vitro Mtb infection. When treating MDMs with 1,25-dihydroxyvitamin D₃, which induces antimicrobial macrophage programs, TREM2 + MDM numbers, lipid droplet abundance and Mtb viability are decreased. Thus, we propose a spatially localized, alveolar pneumonia-intrinsic TREM2⁺ macrophage program that potentially contributes to Mtb persistence in pulmonary TB infection in humans.

  • Open Access

    Spatial transcriptomics atlas of inflammatory bowel disease to guide implementation in research consortiums and clinical trials

    by Yiming Li, Cenfu Wei, Wenjing Yang, Hai Wang, Alan Robinson, Isabella Peshek, Tianming Yu, Jiwoon Park, Jenny Yanyi Ding, Stephen B. Hanauer, et al.

    Using over 100 intestinal tissue sections from non-diseased controls and patients with ulcerative colitis or Crohn’s disease across multiple inflammatory bowel disease consortia, we construct a spatially resolved atlas containing over three million cells and systematically evaluate two imaging-based spatial transcriptomics platforms. Here we show that CosMx tends to achieve higher detection efficiency than Xenium across commercially available panels in both ulcerative colitis and Crohn’s disease, whereas Xenium shows reduced performance associated with tissue type, block quality, and panel size. CosMx identifies regulatory T cell associated biology in both disease subtypes, which we validate using independent laboratory experiments and multi-plex spatial multi-omics. CosMx’s data quality remains stable across variation in fixation time and sectioning procedures, supporting its operational feasibility for multi-center studies. This study establishes a technical and biological benchmark for the application of single-cell-resolved spatial transcriptomics in gastrointestinal tissue, enabling more reliable application of spatial technologies in translational inflammatory bowel disease research.


  • Open Access

    Spatially separated epithelium-associated and lamina propria neutrophils present distinct functional identities in the inflamed colon mucosa

    by Lenore K. Yalom, Caroline J. Herrnreiter, Triet M. Bui, Joey Lockhart, Enzo B. Piccolo, Xingsheng Ren, Cenfu Wei, Anastasiia Serdiukova, Edward B. Thorp, Parambir S. Dulai, et al.


  • Open Access

    Calcium channel-coupled transcription factors facilitate direct nuclear signaling

    by Eshaan R. Rao, Tyler Thaxton, Eric Gama, Jack Godfrey, Cenfu Wei, Qiaoshan Lin, Yan Li, Daniel Parviz Hejazi Pastor, Christian Hansel, Xiaofei Du, et al.

    Summary: VGCCs play crucial roles within the CNS, in maintaining cell excitability, enabling activity- dependent neuronal development, and forming long-term memory by regulating Ca 2+ influx. The intracellular carboxyl-terminal domains of VGCC α1 subunits help regulate VGCC function. Emerging evidence suggests that some VGCC C-termini have functions independent of channel gating and exist as stable proteins. Here, we demonstrate that all VGCC gene family members express bicistronic mRNA transcripts that produce functionally distinct C-terminal proteins (CTPs) in tandem with full-length VGCC α1 subunits. Two of these CTPs, α1CCT and α1ACT, cycle to and from the nucleus in a Ca 2+ - and calmodulin-dependent fashion. α1CCT, α1ACT, and α1HCT regulate chromatin accessibility and/or bind directly to genes, regulating gene networks involved in neuronal differentiation and synaptic function in a Ca 2+ -dependent manner. This study elucidates a conserved process of coordinated protein expression within the VGCC family, coupling the channel function with VGCC C-terminal transcription factors.